Lotus Bio-Technology Development Corp.
LBTD · OTC
3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $2 | $0 |
| Short-Term Investments | -$0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $0 | $2 | $0 |
| Property Plant & Equip (Net) | $5 | $5 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $5 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$5 | -$5 | $0 | $0 |
| Total NC Assets | $5 | $5 | $0 | $0 |
| Other Assets | -$5 | $0 | $0 | $0 |
| Total Assets | $0 | $5 | $2 | $0 |
| Liabilities | – | – | – | – |
| Payables | $12 | $15 | $9 | $6 |
| Short-Term Debt | $6 | $51 | $0 | $34 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $63 | $0 | $38 | $13 |
| Total Curr. Liab. | $81 | $67 | $47 | $52 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81 | $67 | $47 | $52 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $2 | $60,000 |
| Retained Earnings | -$949 | -$929 | -$148 | -$155 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $887 | $867 | $101 | -$59,897 |
| Total Equity | -$61 | -$61 | -$45 | -$52 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $5 | $2 | $0 |
| Net Debt | $6 | $51 | -$2 | $34 |